Tracy Felland

Title: Tracy Felland: Innovator in Antibiotic Resistance Testing

Introduction

Tracy Felland is a notable inventor based in Sacramento, CA, who has made significant contributions to the field of microbiology. His work primarily focuses on the development of innovative testing methods for antibiotic resistance, which is a growing concern in healthcare.

Latest Patents

Felland holds a patent for the "Rapid Inducible Beta-Lactamase Screen Test." This assay is designed to determine beta-lactam antibiotic resistance in target bacterial strains. The method involves growing the bacterial strain in the presence of both a beta-lactamase inducing antibiotic and a beta-lactam indicator antibiotic, which is unable to hydrolyze beta-lactam antibiotics. The growth of the bacteria, indicative of drug resistance, is monitored by detecting a fluorophor released through the enzymatic cleavage of a metabolizable fluorogenic compound.

Career Highlights

Tracy Felland is currently employed at Dade Microscan Inc., where he continues to advance his research in antibiotic resistance. His innovative approach to testing has the potential to improve clinical outcomes by enabling faster and more accurate detection of resistant bacterial strains.

Collaborations

Felland collaborates with talented professionals in his field, including Judith Johnston and Shoshana Bascomb, who contribute to the research and development efforts at Dade Microscan Inc.

Conclusion

Tracy Felland's work in developing rapid testing methods for antibiotic resistance highlights the importance of innovation in addressing public health challenges. His contributions are vital in the ongoing fight against antibiotic-resistant bacteria.